EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹2.24 Cr | ₹2.00 Cr | ₹4.52 Cr | ₹4.15 Cr | ₹3.89 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of EVEREST ORGANICS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹2.24 Cr |
| Mar2025 | ₹2.00 Cr |
| Mar2024 | ₹4.52 Cr |
| Mar2023 | ₹4.15 Cr |
| Mar2022 | ₹3.89 Cr |
How is Deferred Tax Assets / Liabilities of EVEREST ORGANICS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.24 Cr | 11.63 | |
| Mar2025 | ₹2.00 Cr | -55.63 | |
| Mar2024 | ₹4.52 Cr | 8.95 | |
| Mar2023 | ₹4.15 Cr | 6.61 | |
| Mar2022 | ₹3.89 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹255.0 Cr | 6.3% | 5.9% | -37.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 6.3% |
5.9% |
-37.2% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses